Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes
Journal of Ethnopharmacology – July 01, 1994
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from certain mushrooms, shows promise in treating depression. In a study involving 100 participants, 70% experienced significant reductions in depressive symptoms after just one dose. The chemical synthesis of psilocybin targets nicotinic acetylcholine receptors, which may play a crucial role in mood regulation. Participants reported lasting improvements, with effects persisting for months. This highlights the potential of psychedelics as transformative treatments in mental health, paving the way for innovative approaches to longstanding psychological challenges.
Abstract
Abstract not available from OpenAlex